Cochlear pathology in preeclamptic rats: protective effects of vitamin D and magnesium sulfate
Authors:
- Mustafa AltintaşMAMustafa Altintaş
- Alexandra CernomorcenoACAlexandra Cernomorceno
- Nuray Ensari̇NENuray Ensari̇
- Nevreste Di̇dEm Sonbay YilmazNYNevreste Di̇dEm Sonbay Yilmaz
- Özer Erdem GürÖGÖzer Erdem Gür
- Hülya Eyi̇gÖrHEHülya Eyi̇gÖr
- Züleyha Di̇lEk GülmezZGZüleyha Di̇lEk Gülmez
- Erdoğan BulutEBErdoğan Bulut
- Serap Şi̇rVanciSŞSerap Şi̇rVanci
- Selahatti̇n KumruSKSelahatti̇n Kumru
Open Access
- 12 December 2023
- journal article
- research article
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 53 (6) , 1614-1620
Abstract
Background/aim: This study investigated the possible degeneration in cochlear morphology induced by preeclampsia (PE) and the therapeutic/preventive effect of vitamin D (Vit D) and magnesium sulfate (MgSO4) used separately and together on feto-maternal outcomes. Materials and methods: We created PE in rats using a reduced uterine perfusion pressure (RUPP) animal model and recorded blood pressure (BP), embryonic survival (ES), and embryonic weight (EW) and evaluated cochlear morphology by electron microscopy. Results: The PE group had elevated BP, a decreased number and weight of live pups, and significant degeneration in the cochlea compared to the sham group. In the PEV group, we observed significant beneficial effects of Vit D supplementation at 14.5 and 19.5 dpc in terms of BP (p < 0.05), EW (p < 0.001), and cochlear degeneration compared to the PE group. In the PEM group, BP (p < 0.05) and cochlear degeneration nearly reached the level found in the sham group. However, although the EW was statistically different in the PE group, it did not reach sham group levels. We also observed that BP returned to sham level (p < 0.01) and noticed significant increases in the EW (p < 0.0001) and ES (p = 0.017) in the PEMV group compared to the PE group. According to the scanning electron microscope results, combined administration of VitD and MgSO4 is more effective than separate administration in improving cochlear degeneration induced by PE. Conclusion: The administration of Vit D and MgSO4 during pregnancy has beneficial effects on PE pathology and may play a significant role in preventing PE-related complications, including cochlear degeneration.Keywords
This publication has 18 references indexed in Scilit:
- Vitamin D supplementation during pregnancy: Updated meta-analysis on maternal outcomesThe Journal of Steroid Biochemistry and Molecular Biology, 2016
- Vitamin D supplementation improves pathophysiology in a rat model of preeclampsiaAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2016
- Placental ischemia increases seizure susceptibility and cerebrospinal fluid cytokinesPhysiological Reports, 2015
- Hearing loss: An unknown complication of pre‐eclampsia?Journal of Obstetrics and Gynaecology Research, 2014
- Magnesium sulfate therapy of preeclampsia: an old tool with new mechanism of action and prospect in management and prophylaxisHypertension Research, 2012
- Changes in guinea pig cochlea after transient cochlear ischemiaNeuroReport, 2010
- Is Preeclampsia a New Risk Factor for Cochlear Damage and Hearing Loss?Otology & Neurotology, 2010
- Preeclampsia: The Role of Angiogenic Factors in Its PathogenesisPhysiology, 2009
- Hearing impairment in pregnancy toxemiaOtolaryngology–Head and Neck Surgery, 2008
- Reduced Uterine Perfusion Pressure During Pregnancy in the Rat Is Associated With Increases in Arterial Pressure and Changes in Renal Nitric OxideHypertension, 2001